3
CLINICAL TRIALS
Safety and Effectiveness Study
7KH$QJLR6HDO9DVFXODU&ORVXUH'HYLFHZLWKDVHOIWLJKWHQLQJVXWXUHZDVHYDOXDWHGLQDPXOWLFHQWHUQRQUDQGRPL]HGVWXG\GHVLJQHGWRH[DPLQHWKHVDIHW\DQGHႇHFWLYHQHVVRIIHPRUDO
DUWHU\FORVXUHXVLQJWKH)DQG)$QJLR6HDOGHYLFHIROORZLQJDUWHULDOFDQQXODWLRQGXULQJGLDJQRVWLFDQJLRJUDSK\DQGSHUFXWDQHRXVFRURQDU\LQWHUYHQWLRQSURFHGXUHV
7KHVWXG\ZDVFRQGXFWHGLQWKH8QLWHG6WDWHVDWQLQHLQVWLWXWLRQVLQYROYLQJSDWLHQWV3DWLHQWVHOLJLEOHIRUSDUWLFLSDWLRQLQFOXGHGFDQGLGDWHVIRUHDUO\DPEXODWLRQDQGSDWLHQWVZKRZHUH
clinically indicated for a diagnostic or an interventional cardiac procedure involving access through the femoral artery using an 8F sheath or smaller for the 8F Angio-Seal or a 6F sheath
RUVPDOOHUIRUWKH)$QJLR6HDO([FOXVLRQFULWHULDLQFOXGHGSDWLHQWVZLWKNQRZQDOOHUJLHVWRWKHPDWHULDOVXVHGLQWKHGHYLFHVHYHUHDFXWHQRQFDUGLDFV\VWHPLFGLVHDVHHYLGHQFHRI
V\VWHPLFLQIHFWLRQFRDJXORSDWK\WKURPERO\WLFPHGLFDWLRQXVHUHGXFLQJ¿EULQRJHQWROHVVWKDQPJGOXVHRILQWUDDRUWLFEDOORRQSXPSVXSSRUWLSVLODWHUDOVKHDWKLQSODFHIRUPRUH
WKDQKRXUVVXVSHFWHGGRXEOHZDOOSXQFWXUHSUHH[LVWLQJKHPDWRPDSUHJQDQF\ODFWDWLRQRULQGLFDWLRQWKDWWKHSXQFWXUHKDGEHHQPDGHLQWKHSURIXQGDIHPRULVRUDWWKHELIXUFDWLRQRI
WKHFRPPRQIHPRUDODUWHU\
3DWLHQWV¶DJHVUDQJHGEHWZHHQPHDQ0RVWRIWKHSDWLHQWVZHUHPDOH7KH)$QJLR6HDOZDVXVHGLQGLDJQRVWLFSDWLHQWVDQG
LQWHUYHQWLRQDOSDWLHQWV$WRWDORILQWHUYHQWLRQDOSDWLHQWVZHUHEHLQJWUHDWHGZLWK*3,,E,,,DLQKLELWRUV7KHPHDQDFWLYDWHGFORWWLQJWLPHIRULQWHUYHQWLRQDOSDWLHQWVZDV
VHFRQGV
7KHHႇHFWLYHQHVVRIWKH$QJLR6HDOGHYLFHZDVHYDOXDWHGE\WLPHVWRKHPRVWDVLVDQGDPEXODWLRQ7LPHWRKHPRVWDWVLVZDVGH¿QHGDVWKHHODSVHGWLPHIURPGHYLFHGHSOR\PHQW
XQWLOFHVVDWLRQRIEOHHGLQJ7LPHWRDPEXODWLRQZDVGH¿QHGDVWKHHODSVHGWLPHIURPGHYLFHGHSOR\PHQWWRWKHWLPHWKHSDWLHQWZDONHGIRU¿YHPLQXWHVRUIHHW0DMRUDQGRYHUDOO
FRPSOLFDWLRQUDWHVFRPSULVHGWKHVDIHW\HQGSRLQWV$PDMRUFRPSOLFDWLRQZDVGH¿QHGDVVXUJLFDOYDVFXODUUHSDLUEOHHGLQJUHTXLULQJWUDQVIXVLRQLQIHFWLRQH[WHQGLQJKRVSLWDOL]DWLRQDQG
SVHXGRDQHXU\VP$9¿VWXODGHHSYHLQWKURPERVLVRUUHWURSHULWRQHDOEOHHGLQJWKDWUHTXLUHGWUHDWPHQWE\VXUJLFDOLQWHUYHQWLRQRUXOWUDVRXQGJXLGHGFRPSUHVVLRQ'DWDZHUHDQDO\]HG
VHSDUDWHO\LQGLDJQRVWLF)LQWHUYHQWLRQDODQG)LQWHUYHQWLRQDODUPV
Effectiveness Results
7KHUHVXOWVRIWKHHႇHFWLYHQHVVPHDVXUHVDUHVXPPDUL]HGLQ7DEOHVDQG
Table 2: Time to Hemostasis
Time to Hemostasis
(minutes)
Diagnostic
Patients (n = 97)
8F Interventional
Patients (n = 105)*
6F Interventional
Patients (n = 103)
0HDQ6'
Range
0-10
Distribution
t = 0
W
W
W
W
W!
&XPXODWLYH1
&XPXODWLYH1
&XPXODWLYH1
,QRQHSDWLHQWWKHSK\VLFLDQORVWDFFHVV1RWLPHWRKHPRVWDVLVZDVUHFRUGHG
Table 3: Time to Ambulation
Time to Ambulation
(hours)
Diagnostic
(n = 92)
8F Interventional
(n = 98)
6F Interventional
(n = 99)
0HDQ6'
Range
Distribution*
W
W
W
W
W
W
W
W!
&XPXODWLYH1
&XPXODWLYH1
&XPXODWLYH1
7LPHWRDPEXODWLRQYDULHGDFURVVLQYHVWLJDWLRQDOFHQWHUVDQGPD\KDYHEHHQDUHVXOWRIYDULDEOHFOLQLFDODSSURDFKHVWDNHQE\SK\VLFLDQVZKHQDPEXODWLQJSDWLHQWV
Early Ambulation and Discharge Study in 6F Diagnostic Patients
,QDFOLQLFDOVWXG\WRHYDOXDWHVDIHW\DQGHႈFDF\RIHDUO\DPEXODWLRQDQGGLVFKDUJHWKH$QJLR6HDO676GHYLFHZDVFOLQLFDOO\HYDOXDWHGLQSDWLHQWVZKRKDGXQGHUJRQHGLDJQRVWLF
DQJLRJUDSK\SURFHGXUHVXVLQJD)UHQFKRUVPDOOHUSURFHGXUDOVKHDWK7KH$QJLR6HDO676ZDVHYDOXDWHGIRUVDIHW\DQGHႈFDF\ZKHQDPEXODWLQJSDWLHQWVDVVRRQDVSRVVLEOH
IROORZLQJGHYLFHGHSOR\PHQWDQGGLVFKDUJLQJSDWLHQWVDVHDUO\DVPLQXWHVIROORZLQJDPEXODWLRQ
Methods:
3DWLHQWVZKRPHWDOOLQFOXVLRQDQGQRH[FOXVLRQFULWHULDZHUHHQUROOHGGXULQJDSUHSURFHGXUHVFUHHQLQJHYDOXDWLRQ)RXU86LQYHVWLJDWLRQDOFHQWHUVSDUWLFLSDWHGLQWKHVWXG\7KHSULPDU\
HQGSRLQWVVWXGLHGZHUHUDWHRIPDMRUFRPSOLFDWLRQVWLPHWRDPEXODWLRQDQGWLPHWRGLVFKDUJH
